US EditionPublished • loading... • Updated
Vaxxas secures TGA licence to expand manufacturing of therapeutic goods in Brisbane
Summary by Australian Manufacturing
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Vaxxas secures TGA licence to expand manufacturing of therapeutic goods in Brisbane
Australian biotechnology company Vaxxas has been granted a Therapeutic Goods Administration licence to manufacture therapeutic goods, clearing the way for GMP-compliant manufacturing at its Brisbane biomedical facility and supporting the progression of clinical trials for its proprietary high-density microarray patch technology.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
